Boulder-based N30 Pharma names R. Michael Carruthers as CFO
N30 Pharmaceuticals Inc., a Boulder-based firm developing drug therapies for cystic fibrosis, appointed former Array BioPharma executive R. Michael Carruthers as chief financial officer, officials announced Tuesday.
No comments:
Post a Comment